Back
Hepion Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
23
HEPA
Hepion Pharmaceuticals
Last Price:
0.65
Seasonality Move:
10.8%
Sell
48
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-7.72%
Sell
23
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy, Sell or Hold?
- The current Hepion Pharmaceuticals [HEPA] share price is $0.63. The Score for HEPA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- HEPA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.78. The Score for NBY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HEPA Stock Price Chart
What is Hepion Pharmaceuticals's stock price today?
-
The Hepion Pharmaceuticals share price today is $0.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.78
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
HEPA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 45.12 | Sell |
Chaikin Money Flow: | -30750 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.72) | Sell |
Bollinger Bands (100): | (0.61 - 0.91) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 63.49 | Buy |
Chaikin Money Flow: | 94062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.59 - 0.73) | Buy |
Bollinger Bands (100): | (0.29 - 1.65) | Sell |
HEPA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.64 | Sell |
20-day SMA: | 0.67 | Sell |
50-day SMA: | 0.67 | Sell |
200-day SMA: | 1.28 | Sell |
8-day EMA: | 0.64 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.69 | Sell |
200-day EMA: | 1.72 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.73 | Buy |
20-day SMA: | 0.66 | Buy |
50-day SMA: | 0.62 | Buy |
200-day SMA: | 2.52 | Sell |
8-day EMA: | 0.72 | Buy |
20-day EMA: | 0.69 | Buy |
50-day EMA: | 0.74 | Buy |
200-day EMA: | 5.97 | Sell |
Hepion Pharmaceuticals Earnings Growth & HEPA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Hepion Pharmaceuticals Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |